Published September 2013 | Version v1
Journal article

The PERK/ATF4/LAMP3-arm of the unfolded protein response affects radioresistance by interfering with the DNA damage response

  • 1. Department of Laboratory Medicine, Radboud University Nijmegen Medical Centre (Netherlands)
  • 2. Department of Radiation Oncology, Radboud University Nijmegen Medical Centre (Netherlands)

Description

Background and purpose: Lysosome-associated membrane protein 3 (LAMP3) is induced by the PKR-like ER kinase (PERK)/activating transcription factor 4 (ATF4)-arm of the unfolded protein response (UPR) during hypoxia. LAMP3 has prognostic value in breast cancer patients treated with radiotherapy. Here, we specifically investigated the role of the PERK/ATF4/LAMP3-arm in the radiation response of breast cancer cells. Material and methods: Radiosensitivity of breast cancer cells was examined after siRNA-mediated knockdown of PERK, ATF4 and LAMP3. Activation of DNA damage repair proteins was evaluated by Western blotting and immunocytochemistry. Results: Knockdown of the PERK/ATF4/LAMP3-arm and chemical inhibition of PERK could radiosensitise MDA-MB-231 cells significantly. Western blot analysis of several DNA damage repair proteins showed that LAMP3 knockdowns had an attenuated DNA damage response after radiation compared to controls. γ-H2AX foci analysis revealed that LAMP3 knockdowns had a reduced number of positive cells after irradiation, indicating that their DNA damage repair signalling response is decreased. In addition, the effect of autophagy inhibition was examined and revealed a radiosensitising effect and the presence of residual γ-H2AX foci. Conclusions: The PERK/ATF4/LAMP3-arm causes radioresistance of breast cancer cells by increasing DNA damage repair signalling. Inhibition of PERK and/or autophagy may sensitise tumours to radiotherapy

Availability note (English)

Available from http://dx.doi.org/10.1016/j.radonc.2013.06.037

Additional details

Identifiers

DOI
10.1016/j.radonc.2013.06.037;
PII
S0167-8140(13)00316-2;

Publishing Information

Journal Title
Radiotherapy and Oncology
Journal Volume
108
Journal Issue
3
Journal Page Range
p. 415-421
ISSN
0167-8140
CODEN
RAONDT

INIS

Country of Publication
Ireland
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
45091632
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
DNA DAMAGES; MAMMARY GLANDS; MEMBRANE PROTEINS; NEOPLASMS; RADIOSENSITIVITY; RADIOTHERAPY; TRANSCRIPTION FACTORS
Descriptors DEC
BODY; DISEASES; GLANDS; MEDICINE; NUCLEAR MEDICINE; ORGANIC COMPOUNDS; ORGANS; PROTEINS; RADIOLOGY; SENSITIVITY; THERAPY

Optional Information

Copyright
Copyright (c) 2013 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.